Intravenous plus intravitreal erythropoietin for management of methanol toxicity optic neuropathy: A case report and brief review

  • Rashidi Alavijeh M
  • Mazaheri‐Tehrani S
  • Saffari A
  • et al.
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Methanol can inhibit cellular aerobic respiration pathway and causes cell hypoxia specially in optic neurons. Despite using many drugs, methanol‐induced optic neuropathy (MION) still has a poor prognosis. Here we present a case of MION which is managed by a combination of intravenous and intravitreal erythropoietin in addition to corticosteroids.Despite usage of many drugs, methanol induced optic neuropathy (MION) is still poor prognosis. Combination of intravenous and intravitreal erythropoietin in addition to corticosteroid can be an opportunity to treat MION.

Cite

CITATION STYLE

APA

Rashidi Alavijeh, M., Mazaheri‐Tehrani, S., Saffari, A. S., Fazel, M., & Fazel, F. (2023). Intravenous plus intravitreal erythropoietin for management of methanol toxicity optic neuropathy: A case report and brief review. Clinical Case Reports, 11(3). https://doi.org/10.1002/ccr3.7011

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free